Abstract
Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial (S22.005)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have